Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana

Plant Biotechnology Journal

Volumn 9, Issue 7, 2011, Pages 807-816

  Phoolcharoen, Waranyoo ^a   Bhoo, Seong H ^b   Lai, Huafang ^a   Ma, Julian ^c   Arntzen, Charles J ^a   Chen, Qiang ^a,d   Mason, Hugh S ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b Kyung Hee University   (South Korea)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Ebola virus; Geminiviral replicon system; Immune complex; Nicotiana benthamiana; Plant vaccine

Indexed keywords

COMPLEMENT COMPONENT C1Q; ENVELOPE GLYCOPROTEIN, EBOLA VIRUS; HYBRID PROTEIN; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; FEMALE; GEMINIVIRUS; GENE EXPRESSION; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; PHENOTYPE; PLANT LEAF; REPLICON; TOBACCO; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGEN-ANTIBODY COMPLEX; COMPLEMENT C1Q; EBOLAVIRUS; FEMALE; GEMINIVIRIDAE; GENE EXPRESSION; GENETIC VECTORS; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PHENOTYPE; PLANT LEAVES; RECOMBINANT FUSION PROTEINS; REPLICON; TOBACCO; VACCINATION; VIRAL ENVELOPE PROTEINS;

EBOLA VIRUS; LAKE VICTORIA MARBURGVIRUS; MUS; NICOTIANA BENTHAMIANA; PRIMATES;

EID: 79961171492     PISSN: 14677644     EISSN: 14677652     Source Type: Journal    
DOI: 10.1111/j.1467-7652.2011.00593.x     Document Type: Article

References (58)

1. Alexopoulou, L., Holt, A.C., Medzhitov, R. and Flavell, R.A. (2001) Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature, 413, 732.
2. Arntzen, C.J. (2008) Plant science. Using tobacco to treat cancer. Science, 321, 1052-1053.
3. Bachmann, M.F., Kundig, T.M., Hengartner, H. and Zinkernagel, R.M. (1994) Regulation of IgG antibody titers by the amount persisting of immune-complexed antigen. Eur. J. Immunol., 24, 2567-2570.
4. Bajtay, Z., Csomor, E., Sandor, N. and Erdei, A. (2006) Expression and role of Fc- and complement-receptors on human dendritic cells. Immunol. Lett., 104, 46-52.
5. Castilho, A., Strasser, R., Stadlmann, J., Grass, J., Jez, J., Gattinger, P., Kunert, R., Quendler, H., Pabst, M., Leonard, R., Altmann, F. and Steinkellner, H. (2010) In planta protein sialylation through over-expression of the respective mammalian pathway. J. Biol. Chem., 285, 15923-15930.
6. Chan, S.Y., Ma, M.C. and Goldsmith, M.A. (2000) Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Gen. Virol., 81, 2155-2159.
7. Chargelegue, D., Drake, P.M., Obregon, P., Prada, A., Fairweather, N. and Ma, J.K. (2005) Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants. Infect. Immun., 73, 5915-5922.
8. Das, D., Jacobs, F., Feldmann, H., Jones, S.M. and Suresh, M.R. (2007) Differential expression of the Ebola virus GP(1, 2) protein and its fragments in E. coli. Protein Expr. Purif., 54, 117-125.
9. Dieryck, W., Pagnier, J., Poyart, C., Marden, M.C., Gruber, V., Bournat, P., Baudino, S. and Merot, B. (1997) Human haemoglobin from transgenic tobacco. Nature, 386, 29-30.
10. Dietrich, C. and Maiss, E. (2003) Fluorescent labelling reveals spatial separation of potyvirus populations in mixed infected Nicotiana benthamiana plants. J. Gen. Virol., 84, 2871-2876.
11. Ellis, D.S., Simpson, I.H., Francis, D.P., Knobloch, J., Bowen, E.T., Lolik, P. and Deng, I.M. (1978) Ultrastructure of Ebola virus particles in human liver. J. Clin. Pathol., 31, 201-208.
12. Feldmann, H., Will, C., Schikore, M., Slenczka, W. and Klenk, H.D. (1991) Glycosylation and oligomerization of the spike protein of Marburg virus. Virology, 182, 353-356.
13. Feldmann, H., Nichol, S.T., Klenk, H.D., Peters, C.J. and Sanchez, A. (1994) Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology, 199, 469-473.
14. Geisbert, T.W., Daddario-Dicaprio, K.M., Geisbert, J.B., Reed, D.S., Feldmann, F., Grolla, A., Stroher, U., Fritz, E.A., Hensley, L.E., Jones, S.M. and Feldmann, H. (2008) Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine, 26, 6894-6900.
15. Geisbert, T.W., Geisbert, J.B., Leung, A., Daddario-DiCaprio, K.M., Hensley, L.E., Grolla, A. and Feldmann, H. (2009) Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus. J. Virol., 83, 7296-7304.
16. Geyer, B.C., Kannan, L., Cherni, I., Woods, R.R., Soreq, H. and Mor, T.S. (2010) Transgenic plants as a source for the bioscavenging enzyme, human butyrylcholinesterase. Plant Biotechnol. J., 8, 1-14.
17. Giritch, A., Marillonnet, S., Engler, C., van Eldik, G., Botterman, J., Klimyuk, V. and Gleba, Y. (2006) Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proc. Natl Acad. Sci. USA, 103, 14701-14706.
18. Gleba, Y., Marillonnet, S. and Klimyuk, V. (2004) Engineering viral expression vectors for plants: the 'full virus' and the 'deconstructed virus' strategies. Curr. Opin. Plant Biol., 7, 182-188.
19. Gleba, Y., Klimyuk, V. and Marillonnet, S. (2005) Magnifection - a new platform for expressing recombinant vaccines in plants. Vaccine, 23, 2042-2048.
20. Gleba, Y., Klimyuk, V. and Marillonnet, S. (2007) Viral vectors for the expression of proteins in plants. Curr. Opin. Biotechnol., 18, 134-141.
21. Gutierrez, C. (1999) Geminivirus DNA replication. Cell. Mol. Life Sci., 56, 313-329.
22. Hensley, L.E., Mulangu, S., Asiedu, C., Johnson, J., Honko, A.N., Stanley, D., Fabozzi, G., Nichol, S.T., Ksiazek, T.G., Rollin, P.E., Wahl-Jensen, V., Bailey, M., Jahrling, P.B., Roederer, M., Koup, R.A. and Sullivan, N.J. (2010). Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species. PLoS Pathog., 6, e1000904.
23. Heyman, B. (2000) Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol., 18, 709-737.
24. Huang, Z., Chen, Q., Hjelm, B., Arntzen, C. and Mason, H. (2009) A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol. Bioeng., 103, 706-714.
25. Huang, Z., Phoolcharoen, W., Lai, H., Piensook, K., Cardineau, G., Zeitlin, L., Whaley, K.J., Arntzen, C.J., Mason, H.S. and Chen, Q. (2010) High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnol. Bioeng., 106, 9-17.
26. Hull, R. and Plaskitt, A. (1970) Electron microscopy on the behavior of two strains of alfalfa mosaic virus in mixed infections. Virology, 42, 773-776.
27. de Jong, J.M., Schuurhuis, D.H., Ioan-Facsinay, A., van der Voort, E.I., Huizinga, T.W., Ossendorp, F., Toes, R.E. and Verbeek, J.S. (2006) Murine Fc receptors for IgG are redundant in facilitating presentation of immune complex derived antigen to CD8+ T cells in vivo. Mol. Immunol., 43, 2045-2050.
28. Judge, N.A., Mason, H.S. and O'Brien, A.D. (2004) Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces. Infect. Immun., 72, 168-175.
29. Kim, K.I., Sunter, G., Bisaro, D.M. and Chung, I.S. (2007) Improved expression of recombinant GFP using a replicating vector based on Beet curly top virus in leaf-disks and infiltrated Nicotiana benthamiana leaves. Plant Mol. Biol., 64, 103-112.
30. Krieger, G., Kneba, M., Bolz, I., Volling, P., Wessels, J. and Nagel, G.A. (1985) Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum. J. Clin. Lab. Immunol., 18, 129-134.
31. Laufs, J., Jupin, I., David, C., Schumacher, S., Heyraud-Nitschke, F. and Gronenborn, B. (1995) Geminivirus replication: genetic and biochemical characterization of Rep protein function, a review. Biochimie, 77, 765-773.
32. Lee, J.E., Fusco, M.L., Hessell, A.J., Oswald, W.B., Burton, D.R. and Saphire, E.O. (2008) Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature, 454, 177-182.
33. Malashkevich, V.N., Schneider, B.J., McNally, M.L., Milhollen, M.A., Pang, J.X. and Kim, P.S. (1999) Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. Proc. Natl. Acad. Sci. USA, 96, 2662-2667.
34. Manicassamy, B. and Rong, L. (2009) Expression of Ebolavirus glycoprotein on the target cells enhances viral entry. Virol. J., 6, 75.
35. Marillonnet, S., Giritch, A., Gils, M., Kandzia, R., Klimyuk, V. and Gleba, Y. (2004) In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proc. Natl. Acad. Sci. USA, 101, 6852-6857.
36. Martin, J.E., Sullivan, N.J., Enama, M.E., Gordon, I.J., Roederer, M., Koup, R.A., Bailer, R.T., Chakrabarti, B.K., Bailey, M.A., Gomez, P.L., Andrews, C.A., Moodie, Z., Gu, L., Stein, J.A., Nabel, G.J. and Graham, B.S. (2006) A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial. Clin. Vaccine Immunol., 13, 1267-1277.
37. Melito, P.L., Qiu, X., Fernando, L.M., deVarennes, S.L., Beniac, D.R., Booth, T.F. and Jones, S.M. (2008) The creation of stable cell lines expressing Ebola virus glycoproteins and the matrix protein VP40 and generating Ebola virus-like particles utilizing an ecdysone inducible mammalian expression system. J. Virol. Methods, 148, 237-243.
38. Mellquist-Riemenschneider, J.L., Garrison, A.R., Geisbert, J.B., Saikh, K.U., Heidebrink, K.D., Jahrling, P.B., Ulrich, R.G. and Schmaljohn, C.S. (2003) Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs. Virus Res., 92, 187-193.
39. Mor, T.S., Moon, Y.S., Palmer, K.E. and Mason, H.S. (2003) Geminivirus vectors for high-level expression of foreign proteins in plant cells. Biotechnol. Bioeng., 81, 430-437.
40. Newell, C.A. (2000) Plant transformation technology. Developments and applications. Mol. Biotechnol., 16, 53-65.
41. Pushko, P., Bray, M., Ludwig, G.V., Parker, M., Schmaljohn, A., Sanchez, A., Jahrling, P.B. and Smith, J.F. (2000) Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine, 19, 142-153.
42. Qiu, X., Fernando, L., Alimonti, J.B., Melito, P.L., Feldmann, F., Dick, D., Stroher, U., Feldmann, H. and Jones, S.M. (2009) Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses. PLoS ONE, 4, e5547.
43. Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Thery, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P. and Amigorena, S. (1999) Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med., 189, 371-380.
44. Richardson, J.S., Yao, M.K., Tran, K.N., Croyle, M.A., Strong, J.E., Feldmann, H. and Kobinger, G.P. (2009) Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine. PLoS ONE, 4, e5308.
45. Rybicki, E.P. (2010) Plant-made vaccines for humans and animals. Plant Biotechnol. J., 8, 620-637.
46. Sanchez, A., Yang, Z.Y., Xu, L., Nabel, G.J., Crews, T. and Peters, C.J. (1998) Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J. Virol., 72, 6442-6447.
47. Simmons, G., Wool-Lewis, R.J., Baribaud, F., Netter, R.C. and Bates, P. (2002) Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J. Virol., 76, 2518-2528.
48. Stein, H., Wilensky, M., Tsafrir, Y., Rosenthal, M., Amir, R., Avraham, T., Ofir, K., Dgany, O., Yayon, A. and Shoseyov, O. (2009) Production of bioactive, post-translationally modified, heterotrimeric, human recombinant type-I collagen in transgenic tobacco. Biomacromolecules, 10, 2640-2645.
49. Stenger, D.C., Revington, G.N., Stevenson, M.C. and Bisaro, D.M. (1991) Replicational release of geminivirus genomes from tandemly repeated copies: evidence for rolling-circle replication of a plant viral DNA. Proc. Natl. Acad. Sci. USA, 88, 8029-8033.
50. Sullivan, N.J., Sanchez, A., Rollin, P.E., Yang, Z.Y. and Nabel, G.J. (2000) Development of a preventive vaccine for Ebola virus infection in primates. Nature, 408, 605-609.
51. Sullivan, N.J., Peterson, M., Yang, Z.Y., Kong, W.P., Duckers, H., Nabel, E. and Nabel, G.J. (2005) Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. J. Virol., 79, 547-553.
52. Urade, R. (2007) Cellular response to unfolded proteins in the endoplasmic reticulum of plants. FEBS J., 274, 1152-1171.
53. Warfield, K.L., Swenson, D.L., Olinger, G.G., Kalina, W.V., Aman, M.J. and Bavari, S. (2007) Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. J. Infect. Dis., 196(Suppl 2), S430-S437.
54. Wilson, J.A., Hevey, M., Bakken, R., Guest, S., Bray, M., Schmaljohn, A.L. and Hart, M.K. (2000) Epitopes involved in antibody-mediated protection from Ebola virus. Science, 287, 1664-1666.
55. Wilson, J.A., Bosio, C.M. and Hart, M.K. (2001) Ebola virus: the search for vaccines and treatments. Cell. Mol. Life Sci., 58, 1826-1841.
56. Yang, Z.Y., Duckers, H.J., Sullivan, N.J., Sanchez, A., Nabel, E.G. and Nabel, G.J. (2000) Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med., 6, 886-889.
57. Ye, L., Lin, J., Sun, Y., Bennouna, S., Lo, M., Wu, Q., Bu, Z., Pulendran, B., Compans, R.W. and Yang, C. (2006) Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies. Virology, 351, 260-270.
58. Yusibov, V., Rabindran, S., Commandeur, U., Twyman, R.M. and Fischer, R. (2006) The potential of plant virus vectors for vaccine production. Drugs R D., 7, 203-217.